For the year ending 2025-12-31, ICUI had -$603K decrease in cash & cash equivalents over the period. $91,804K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income (loss) | 732 |
| Depreciation and amortization | 200,741 |
| Operating lease, right-of-use asset, amortization expense | 17,251 |
| Stock compensation | 55,758 |
| Loss on disposition of property plant equipment, net | -5,900 |
| Debt issuance cost amortization | 6,178 |
| Change in fair value of contingent earn-out | 0 |
| Income (loss) from equity method investments | -1,189 |
| Gain (loss) on disposition of business | 44,792 |
| Gain (loss) on extinguishment of debt | -2,463 |
| Other | 24,471 |
| Increase (decrease) in accounts receivable | -8,876 |
| Increase (decrease) in inventories | 26,252 |
| Increase (decrease) in prepaid expense and other assets | 10,958 |
| Increase (decrease) in other operating assets | 6,982 |
| Accounts payable | 6,998 |
| Accrued liabilities | -36,967 |
| Income taxes, including excess tax benefits and deferred income taxes | -24,759 |
| Net cash provided by (used in)operating activities | 179,847 |
| Purchases of property, plant and equipment | 88,043 |
| Proceeds from divestiture of businesses | 211,185 |
| Proceeds from sale of assets | 8,059 |
| Intangible asset additions | 8,972 |
| Proceeds from sale of investment securities | 0 |
| Net cash used in by investing activities | 122,229 |
| Proceeds from issuance of long-term debt, net of lender debt issuance costs | 313 |
| Payments of debt issuance costs | 2,825 |
| Repayments of long-term obligations | 302,750 |
| Payment of third-party debt issuance costs | 1,555 |
| Proceeds from exercise of stock options | 6,106 |
| Payments on finance leases | 2,048 |
| Payment for contingent consideration liability, financing activities | 0 |
| Purchase of treasury stock | 8,766 |
| Net cash (used in) provided by financing activities | -311,525 |
| Effect of exchange rate on cash, cash equivalent, restricted cash, and restricted cash equivalent, continuing operation | 8,846 |
| Cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect, total | -603 |
ICU MEDICAL INC DE (ICUI)
ICU MEDICAL INC DE (ICUI)